Lataa...

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine

BACKGROUND: Cytarabine (ara-C) is the major drug for the treatment of acute myeloid leukemia (AML), but cellular resistance to ara-C is a major obstacle to therapeutic success. The present study examined enhanced anti-apoptosis identified in 3 newly established nucleoside analogue-resistant leukemic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Nishi, Rie, Shigemi, Hiroko, Negoro, Eiju, Okura, Miyuki, Hosono, Naoko, Yamauchi, Takahiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552348/
https://ncbi.nlm.nih.gov/pubmed/33046037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07469-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!